Acrivon Therapeutics, Inc. (ACRV)
$1.75-7.89%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $75M
- Beta
- 1.93
- P/E (TTM)
- -0.93
- Short % float
- 5.79%
- Days to cover
- 4.4
- SI change
- +34.4%
- 1W
- -5.91%
- 1M
- -10.71%
- vs SPY 1W
- -5.78%
- vs SPY 1M
- -13.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ACRV?
- LOPJLB’s latest quantitative signal on Acrivon Therapeutics, Inc. Common Stock (ACRV) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ACRV in?
- Acrivon Therapeutics, Inc. Common Stock (ACRV) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Acrivon Therapeutics, Inc. Common Stock (ACRV) do?
- Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Pro…